MetaCap

Caris Life Sciences Inc. (CAI)

NASDAQ: CAIHealth CareMedical SpecialitiesUSD

17.58-0.96 (-5.18%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CAI stock chart

Technical analysis

Key statistics

All statistics
52-week range
14.19 – 36.50
Day range
17.27 – 18.42
Volume / Avg
4.57M / 4.61M
Beta
—

52-week range

$14.19$36.50

CAI stock today

Caris Life Sciences (CAI) closed at $17.58 on Nov 20, down 5.18% (-$0.96), versus the S&P 500's 3.70% decline. Shares are 51.8% below their 52-week high of $36.50, set on Oct 28, 2026 and 23.9% above the 52-week low of $14.19, near the bottom of the past year's range. CAI is down 34.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 27.0%.

At 10.6x trailing earnings, Caris Life Sciences trades below the peer-group median of 27.1x. Its forward P/E of 64.9x is higher than the trailing multiple, which means analysts expect earnings to decline over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Caris Life Sciences

Company profile

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions; Caris Assure Platform WES/WTS blood-based molecular profiling solutions; Precision Whole Genome Platform, a whole genome sequencing (WGS) blood- and tissue-based profiling solutions; and Caris Detect, a WGS-based multi-cancer early detection solution; Caris WGS MRD a WGS and digital droplet polymerase reaction-based minimal residual disease solution; and Caris ChromoSeq, a WGS and WTS based assay for therapy selection in hematological cancers.

Industry
Medical Specialities
CEO
Dr. David Dean Halbert M.D.
Headquarters
Irving, TX
Employees
1,846
IPO year
2025

Financial highlights

Full financials

In fiscal 2025, Caris Life Sciences generated $812.0 million in revenue, up 97.0% from fiscal 2024, its 2nd consecutive year of revenue growth. Caris Life Sciences reported a net loss of $68.1 million, compared with a loss of $281.9 million a year earlier. Operating margin was 5.6%.

Caris Life Sciences annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023
Revenue$812.03M$412.26M$306.13M
Growth+96.97%+34.67%—
Net income$-68.09M$-281.89M$-341.42M
EPS (diluted)$-3.22$-10.66$-13.24

Analyst forecast

Forecast

Consensus (14 analysts)

buy

Avg. price target

$34.23+94.71%

  • Strong buy 1
  • Buy 9
  • Hold 4
  • Sell 0
  • Strong sell 0

Target range

Low $25.00High $38.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 4, 2026
EPS actual vs est.
$0.05 vs $0.03
Surprise
+66.67%

CAI news

All CAI news

Caris Life Sciences peers

Health Care sector
CAI peer companies
CompanyPrice% ChgMarket capCompare
CONConcentra Group Holdings Parent Inc.41.84+0.94%$5.26Bvs CAI
RDNTRadNet Inc.69.71+0.29%$5.49Bvs CAI
GRALGRAIL Inc.99.25-5.33%$4.46Bvs CAI
BLLNBillionToOne Inc. Class A89.92-0.31%$4.30Bvs CAI
CDNACareDx Inc.70.00-2.67%$3.68Bvs CAI
ACHCAcadia Healthcare Company Inc.34.60+0.38%$3.22Bvs CAI
CELCCelcuity Inc.53.35-5.26%$2.61Bvs CAI
OSCROscar Health Inc. Class A24.73-5.50%$7.68Bvs CAI

Indexes, lists and sector

Caris Life Sciences stock FAQ

What is Caris Life Sciences's stock price today?

CAI last traded at $17.58 as of Nov 20, 4:00 PM EST, down 5.18% on the day. Prices are delayed at least 15 minutes.

What is CAI's P/E ratio?

CAI trades at a trailing P/E ratio of 10.59 and a forward P/E of 64.87, compared with a median of 27.1 for its closest peers.

Who is Caris Life Sciences's CEO?

Dr. David Dean Halbert M.D. is the chief executive officer of Caris Life Sciences Inc., which has about 1,846 employees.

What is the CAI 52-week high?

The 52-week high for CAI is $36.50 and the 52-week low is $14.19. The stock is currently 51.8% below its high.

Compare CAI